MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity and AI-driven solutions, today relaunched as a predictive cybersecurity company, built around a newly assembled team of former U.S. Intelligence Community and private-sector cyber experts. Instead of racing to clean up after a breach, Cycurion is building AI-driven technology designed to see an attack forming and help stop it before operations are touched. The first capability is expected in the coming weeks. The standard is simple to say and hard to meet: see the attack before it surfaces. A data breach now costs a record $4.99 million on average
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Cycurion Relaunches as a Predictive Cybersecurity Company, Powered by AI and Led by Former Intelligence Community and Private-Sector Cyber Experts
- Red Robin Stacks Up the Flavor with the Introduction of the Prime Rib Stack Burger and Fan-Favorite Menu Additions
Red Robin's lineup includes a new limited-time burger, returning fan-favorite burgers to value menu, bottomless refresher beverages and more starting Oct. 19KEY POINTS:Starting Oct. 19, Red Robin's new Prime Rib Stack Burger will be available for a limited time at participating locations nationwide. The Red Robin Prime Rib Stack Burger features a juicy beef burger patty, sliced prime rib, Monterey Jack cheese, caramelized onions and garlic aioli on a black-and-white sesame seed brioche bun, served with a bottomless side.Red Robin is bringing back two fan-favorite burgers, the Bleu Ribbon Burger and Burnin' Love® Burger, that will both be available on the Big YUMMM Deals menu on Oct. 19. Star
- Progressive Reports September 2026 Results
MAYFIELD VILLAGE, OHIO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended September 30, 2026: SeptemberQuarter(millions, except per share amounts and ratios; unaudited) 2026 2025 Change 2026 2025 ChangeNet premiums written$7,255 $7,128 2 %$22,301 $21,384 4 %Net premiums earned$7,160 $6,827 5 %$21,869 $20,849 5 %Net income$630 $305 107 %$2,542 $2,615 (3)%Per share available to common shareholders$1.08 $0.52 109 %$4.37 $4.45 (2)%Total pretax net realized gains (losses) on securities$(231) $138 (267)%$(170) $295 (158)%Combined ratio 90.0 100.4 (10.4)pts. 88.7 89.5 (0.8)pts.Average dilute
- Terra Innovatum Advances Solo™ Industrial Manufacturing Program With ATB and Boldrocchi
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) ("Terra Innovatum" or the "Company"), developer of the SOLO™ Micro-Modular Reactor, today announced significant progress in the industrial manufacturing program for its SOLO™ reactor, following a series of technical and operational activities with key Italian industrial partners ATB Riva Calzoni ("ATB") and Boldrocchi. The activities included manufacturing-process development and factory preparation for the first-of-a-kind (FOAK) SOLO™ reactor at ATB, as well as hot-running testing of critical helium circulation equipment at Boldrocchi. Together, these milestones demonstrate the Company's continued tran
- dLocal to Report Third Quarter 2026 Financial Results
MONTEVIDEO, Uruguay, Oct. 14, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ:DLO, "dLocal" or the "Company")), the leading cross-border payment platform connecting global merchants to emerging markets, intends to release financial results for its third fiscal quarter ended September 30, 2026 on November 12, 2026 after market close. The Company will host a conference call and video webcast on November 12, 2026 at 6:00 p.m. Eastern Time. Please click here to pre-register for the conference call and obtain your dial in number and passcode. The live conference call can be also accessed via audio webcast at the investor relations section of the Company’s website, at https://investor.dlocal.c
- Gevo Announces First Multi-Year Carbon Removal Credits Supply Agreement Through CEEZER
Gevo will supply durable carbon dioxide removal (CDR) credits from Gevo North Dakota, one of the world’s first commercial Bioenergy with Carbon Capture and Storage (BECCS) ethanol plants, under a long-term agreementCEEZER will procure and manage the removal portfolio on behalf of a global Fortune 500 enterprise software company ENGLEWOOD, Colo., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced a three-year agreement with CEEZER, a leading carbon management platform for enterprise customers, for the sale of CDR credits generated at Gevo's North Dakota carbon capture and sequestration project. This first multi-year agreement for Gevo supports its path toward a carb
- CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intellectual property covering novel solid forms of a major, first-in-class respiratory medicine, an asset class addressing a treatment market estimated at more than $20 billion annually. "Sarborg has now built a valuable portfolio of patented solid-form assets, and this filing strengthens its asset base and its prospects as it builds a data package to support licensing and partnership discussions," said James Bligh, Chief Executive Officer of CDT. "As a significant shareholder in Sarborg, CDT is enc
- Genpact Launches Agentic Accounts Receivable Suite to Optimize Cash Flow and Working Capital
Genpact's latest finance and accounting (F&A) Agentic Solution helps reduce past due receivables and increase touchless cash applicationsNEW YORK, Oct. 14, 2026 /PRNewswire/ -- Genpact (NYSE:G), the Agentic Operations company, today announced the general availability of the Genpact Accounts Receivable (AR) Suite for industrial clients in manufacturing and mining. The proprietary agentic AI solution is designed to help automate and coordinate collections, dispute resolution, and cash application across the invoice-to-cash (I2C) process. The suite helps finance teams reduce manual work, prioritize collections activity, resolve disputes faster, and apply customer payments with minimal intervent
- JLL appoints Mark Gibson as Country CEO, US
Newly created role part of firm's Accelerate 2030 strategy to bring the full capabilities of JLL to every client engagementKevin MacKenzie to succeed Gibson as CEO Capital Markets, AmericasKey TakeawaysMark Gibson, currently CEO of Capital Markets Americas, has been appointed to the newly created role of Country CEO, U.S., effective immediately.Gibson will lead a U.S. Executive Committee, focused on ensuring clients benefit from the full depth and breadth of JLL's capabilities with every engagement.The appointment supports "Deepen Client Relationships," one of the six imperatives of Accelerate 2030, JLL's multi-year strategy.Kevin MacKenzie, currently President of Capital Markets Americas, w
- Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century’, NASDAQ:IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the company will attend the upcoming 2026 Jefferies Global Healthcare Conference in London on November 18, 2026. If you are interested in a 1x1 meeting with the Century Therapeutics team during the conference, please reach out to your respective Jefferies representative. About Century Therapeutics Century Therapeutics (NASDAQ:IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iP
- StepStone Launches StepStone Total Portfolio Allocator, Bringing Institutional-Grade Private Markets Intelligence to Portfolio Construction
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- StepStone Group (NASDAQ:STEP), a leading global private markets investment firm, today announced the launch of StepStone Total Portfolio Allocator, an interactive modeling tool that provides wealth management professionals and institutions a more informed way to explore how private markets complement public market portfolios. Designed for private wealth firms and advisors, family offices, multi-family offices, small institutions, and defined contribution plan administrators, the tool makes sophisticated portfolio analysis intuitive and customizable. Leveraging SPI by StepStone, it incorporates unique data points, such as deal-level benchmarking,
- BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ:BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day. Analysts planning to participate in the conference call should register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast for inte
- Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration
Prescription Drug User Fee Act (PDUFA) Target Action Date of March 31, 2027 If Approved, Tab-cel Would Be the First Therapy Available in the U.S. for EBV+ PTLD Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that its partner, Pierre Fabre Pharmaceuticals, Inc. (PFP), has received acceptance by the U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA) resubmission for tabelecleucel, with a proposed indication as monotherapy for treatment of adult and pediatri
- MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
ROCKVILLE, Md., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced preliminary revenue for the third quarter ended September 30, 2026 and raised its 2026 revenue guidance. Preliminary Third Quarter Revenue Core business revenue of approximately $8.1 million in the third quarter of 2026, an increase of 26% compared to the third quarter of 2025.Strategic Platform License (SPL) Program-related revenue of more than $1.0 million, including milestone revenue of $1.0 million received in the thi
- Roseburg Urban Sanitary Authority and Ameresco Celebrate Completion of Energy Infrastructure Project
The completed solar-plus-storage system is designed to offset 100 percent of the Main Office's annual electricity usage while enhancing resilience for critical wastewater operations. Ameresco, Inc., (NYSE:AMRC), a leading energy infrastructure company delivering integrated solutions to create reliable power and modernize infrastructure, today celebrated the completion of a solar-plus-storage project at the main office of the Roseburg Urban Sanitary Authority (RUSA), joined by RUSA Staff, RUSA leadership, the Oregon Department of Energy, Energy Trust of Oregon, and elected officials. The $1M project is the beginning of a multi-phase transformative energy program aimed at enhancing the resi
- Sensata Technologies Announces Brake Force Sensors Enabling Next-Generation Electromechanical Braking Systems in Production EVs
Sensata's Brake Force sensor directly measures clamping force within the brake caliper, providing the real-time feedback required for precise electromechanical brake (EMB) control. Supports improved braking performance, consistency, and safety through high-accuracy force measurement and closed-loop control at each wheel. Enables OEMs to accelerate adoption of brake-by-wire architectures designed for electrification, software-defined vehicles, and advanced driver assistance systems. Sensata Technologies (NYSE:ST), today announced its brake force sensors are now enabling electromechanical braking (EMB) systems in leading electric vehicles. This milestone marks a significant step in
- Howmet Aerospace Board Approves Common Stock Dividend
PITTSBURGH, Oct. 14, 2026 /PRNewswire/ -- The Board of Directors of Howmet Aerospace Inc. (NYSE:HWM) declared a dividend of 14 cents per share on the outstanding Common Stock of the Company, to be paid on November 25, 2026, to the holders of record of the Common Stock at the close of business on November 6, 2026.About Howmet AerospaceHowmet Aerospace Inc., headquartered in Pittsburgh, Pennsylvania, is a leading global provider of advanced engineered solutions for the aerospace, gas turbine and transportation industries. The Company's primary businesses focus on engine components, fastening systems, and airframe structural components necessary for mission-critical performance and efficiency,
- CIBC to launch additional U.S. Canadian Depositary Receipts
Expanded U.S. CDR lineup will provide more opportunities for Canadian investors to access global companiesTORONTO, Oct. 14, 2026 /CNW/ -- Today, CIBC announced its intention to list 11 new U.S. Canadian Depositary Receipts ("CDRs") on the TSX, with trading expected to begin on October 20, 2026. With these additions, CIBC will now offer 144 CDRs across six countries.Introduced to investors over five years ago, CDRs make it easy to gain access and exposure to many of the world's largest companies – in Canadian dollars. Offered at a fraction of the price per share of the underlying reference share, and with a built-in notional currency hedge, CDRs provide investors with affordable access to glo
- Hormel Foods Releases 20th Annual Global Impact Report
The milestone report highlights two decades of global impact and continued progress through the company's Good Feeds Us All frameworkAUSTIN, Minn., Oct. 14, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today released its 20th annual Global Impact Report. The new report, available online, highlights fiscal year 2025 progress through Good Feeds Us All, the framework that guides the company's global impact efforts and focuses on action across its interconnected Planet and Society pillars."For 135 years, Hormel Foods has been guided by the belief that good business and good deeds go hand in hand," said Jeff Ettinger, interim chief executive
- MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Senior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical development, structural biology, and portfolio strategy depth as MindWalk prepares its programs for preclinical efficacy studies MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Or